TCL Archive Trial: Decitabine Improves Survival in Myeloid Leukemia By Cancer History Project July 29, 2011
TCL Archive Gleevec For KIT-positive Tumors Shows 92 Percent Overall Survival By Cancer History Project July 29, 2011
TCL Archive VEGF Levels Can Predict Tumor’s Resistance to Avastin By Cancer History Project July 29, 2011
TCL Archive More Patients Get Screened, Colorectal Death Rates Drop By Cancer History Project July 29, 2011
TCL Archive Revlimid Shows 91 Percent Response in Non-Hodgkin’s By Cancer History Project July 29, 2011
TCL Archive Revlimid Also Demonstrates Response in Mantle Cell By Cancer History Project July 29, 2011
TCL Archive FPD-R Regimen Well-Tolerated, With 63 Percent Complete Response By Cancer History Project July 29, 2011
TCL Archive Overall Cancer Mortality Rates Higher For Men Than Women By Cancer History Project July 29, 2011
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
